PDLI Financial Facts

Operating income: 158.91M
License and other: 0
See Full Income Statement

Total current assets: 341.44M
Total current liabilities: 261.64M
See Full Balance Sheet

PDL BioPharma, Inc. (PDLI) Earnings

  |   Expand Research on PDLI
Next EPS Date N/A EPS Growth Rate +4.0%
Average EPS % Beat Rate +2.6% Revenue Growth Rate -7.0%
Average % Move 1-Wk after EPS +1.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/10/14 Q314 $0.61$0.56 +$0.05$164.6M$165.1M N/A Details
8/18/14 Q214 $0.52$0.46 +$0.06$162.8M$134.07M N/A Details
5/12/14 Q114 $0.44$0.45 -$0.01$139.7M$130.93M N/A Details
3/3/14 Q413 $0.39$0.43 -$0.04$110.1M$115.22M N/A Details
11/6/13 Q313 $0.36$0.37 -$0.01$97.3M$97.09M N/A Details
8/8/13 Q213 $0.62$0.54 +$0.08$143.6M$138.2M N/A Details
5/9/13 Q113 $0.36$0.35 +$0.01$91.8M$91.69M N/A Details
3/1/13 Q412 $0.34$0.32 +$0.02$86M$86.08M N/A Details